Chita-gun, Japan

Satoru Iguchi

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Aichi, JP (2005)
  • Taketoyo-cho, JP (2006)
  • Chita-gun, JP (2009 - 2010)
  • Tsukuba, JP (2017 - 2021)
  • Ibaraki, JP (2021)

Company Filing History:


Years Active: 2005-2021

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Satoru Iguchi: Innovator in Pharmaceutical Chemistry

Introduction

Satoru Iguchi is a prominent inventor based in Chita-gun, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific cancer-related pathways. With a total of 10 patents to his name, Iguchi's work has the potential to impact the treatment of various diseases.

Latest Patents

Iguchi's latest patents include innovative compounds such as substituted pyrrolo[2,3-d]pyrimidines, which serve as HER2 inhibitors. These novel pyrimidine compounds not only inhibit HER2 activity but also exhibit brain penetration properties, making them valuable in pharmaceutical compositions. Another significant patent involves a fused pyrimidine compound aimed at providing RET inhibitory activity, which is crucial for the prevention and treatment of RET-related diseases, particularly cancer.

Career Highlights

Throughout his career, Satoru Iguchi has worked with leading pharmaceutical companies, including Pfizer Corporation and Taiho Pharmaceutical Company Limited. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Iguchi has collaborated with notable colleagues in the field, including Chikara Uchida and Hiroki Sone. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Satoru Iguchi's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the industry. His work continues to pave the way for new treatments in cancer therapy and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…